Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Bristol Myers Squibb Wins USFDA Approval for Opdivo Combo in Hodgkin Lymphoma

Bristol Myers Squibb Repotrectinib application to treat cancer validated by EMA

Written By Ruchika Sharma4 Jan 2024 1:30 PM IST

Princeton: Bristol Myers Squibb has announced that the European Medicines Agency (EMA) has validated its marketing authorization application...

CVS Health to remove AbbVie rheumatoid arthritis drug Humira from some drug reimbursement lists in April

Written By Ruchika Sharma4 Jan 2024 12:30 PM IST

A CVS spokesperson said the company expects most of its customers to transition their coverage to biosimilars of Humira, known chemically as...

Pfizer Sells ViiV Stake for USD 1.9 Billion, Shionogi Emerges Bigger Partner

Pfizer gene therapy for bleeding disorder approved in Canada

Written By Ruchika Sharma4 Jan 2024 11:51 AM IST

Canada: Pfizer said on Wednesday that Canada's health regulator approved its gene therapy for the treatment of a rare inherited bleeding...

Trastuzumab deruxtecan: AstraZeneca India Pharma unveils HER-2 positive metastatic breast cancer therapy

Written By Ruchika Sharma3 Jan 2024 3:59 PM IST

New Delhi: AstraZeneca India Pharma Ltd., a science-led biopharmaceutical company officially launched Trastuzumab deruxtecan, therapy tailored...

USFDA approvals bounce back in 2023, sparking hopes of biotech recovery

Written By Ruchika Sharma3 Jan 2024 3:22 PM IST

The U.S. Food and Drug Administration approved nearly 50% more novel drugs in 2023 than in 2022, putting it back on pace with historical levels, an...

Novartis Loses India Patent on Heart Failure Drug Vymada

Voyager Therapeutics enters Capsid license agreement with Novartis to advance novel gene therapies

Written By Ruchika Sharma3 Jan 2024 2:37 PM IST

Under the terms of the agreement, Novartis has agreed to pay Voyager $100 million of consideration up front, including a $20 million purchase of newly...

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

Boehringer Ingelheim partners with Ribo to develop new treatments for people with liver diseases

Written By Ruchika Sharma3 Jan 2024 1:53 PM IST

Ingelheim: Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo) have announced a collaboration with Boehringer Ingelheim to...

Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case

Moderna jumps on Oppenheimer upgrade, 2025 sales growth goal

Written By Ruchika Sharma3 Jan 2024 9:00 AM IST

According to Oppenheimer, Moderna could have five products on the market by 2026.

Sanofi Gets CDSCO Panel Nod to Update Prescribing Information for Xenpozyme

AstraZeneca-Sanofi Beyfortus gets nod for RSV disease prevention in infants in China

Written By Ruchika Sharma2 Jan 2024 3:06 PM IST

China: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of...

Reckitt's Mead Johnson Nutrition recalls baby formula powder from US

Written By Ruchika Sharma1 Jan 2024 12:12 PM IST

Reckitt Benckiser Group's Mead Johnson Nutrition (MJN) is voluntarily recalling select batches of Nutramigen Powder from the U.S. market due to a...

Breakthrough: World's First Eye Transplant performed in New York

Written By Ruchika Sharma10 Nov 2023 12:00 PM IST

Surgeons in New York have performed the first-ever whole-eye transplant in a human, they announced on Thursday, an accomplishment being hailed as a...

Centre to introduce research linked incentive scheme to cover RnD costs for biotech products: DCGI Dr V G Somani

Written By Ruchika Sharma21 Jan 2023 11:23 AM IST

Underscoring the importance of policy reforms, innovation, and research and development, he said the government has taken several initiatives to aid...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok